Potent and selective A3 adenosine receptor antagonists bearing aminoesters as heterobifunctional moieties
文献信息
Stephanie Federico, Stefano Moro, Sonja Kachler, Karl-Norbert Klotz, Giampiero Spalluto
A3 adenosine receptors were found to have a role in different pathological states, such as glaucoma, renal fibrosis, neuropathic pain and cancer. Consequently, it is important to utilize any molecular tool which could help to study these conditions. In the present study we continue our search for potent A3 adenosine receptor ligands which could be successively conjugated to other molecules with the aim of obtaining more potent (e.g. allosteric ligand conjugation) or detectable ligands (e.g. fluorescent molecule or biotin conjugation). Specifically, different aminoester moieties were introduced at the 5 position of the pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine core. The ester functionalization represents the candidate for the subsequent conjugation. All the reported compounds are potent hA3 adenosine receptor antagonists and some of them exhibited high selectivity against the other adenosine receptors. The main structural terms of ligand recognition and selectivity were disclosed by molecular modelling studies. Molecular docking results led to the characterization of an alternative binding mode for antagonists at the orthosteric binding site of the hA3 adenosine receptor, evaluated and assessed by classical molecular dynamics simulations.
相关文献
Deciphering the pH-dependence of ground- and excited-state equilibria of thienoguanine
Pascal Didier, Jagannath Kuchlyan, Lara Martinez-Fernandez, Pauline Gosset, Jérémie Léonard, Yitzhak Tor, Roberto Improta, Yves Mély
DOI: 10.1039/C9CP06931C
Clarifying the impacts of surface hydroxyls on CO oxidation on CeO2(100) surfaces: a DFT+U study
Hui Zhou, Dong Wang, Xue-Qing Gong
DOI: 10.1039/D0CP00204F
The structural α-relaxation times of prilocaine confined in 1 nm pores of molecular sieves: quantitative explanation by the coupling model
K. L. Ngai, Z. Wojnarowska, Marian Paluch
DOI: 10.1039/D0CP00282H
CPMD investigation of α-RDX and ε-CL-20: the transition of deflagration to detonation depending on the self-produced radicals
Tiantian Zhang, Longjiu Cheng, Jianguo Zhang, Kun Wang
DOI: 10.1039/D0CP00050G
Characterisation of the temperature-dependent M1 to R phase transition in W-doped VO2 nanorod aggregates by Rietveld refinement and theoretical modelling
Dianhui Wang, Jihui Liang, Chaohao Hu, Lixian Sun, Craig A. J. Fisher
DOI: 10.1039/D0CP01058H
Impact of t-butyl substitution in a rubrene emitter for solid state NIR-to-visible photon upconversion
Edvinas Radiunas, Manvydas Dapkevičius, Steponas Raišys, Saulius Juršėnas, Augustina Jozeliūnaitė, Tomas Javorskis, Ugnė Šinkevičiūtė, Edvinas Orentas, Karolis Kazlauskas
DOI: 10.1039/D0CP00144A
Incorporation of trivalent cations in NaX zeolite nanocrystals for the adsorption of O2 in the presence of CO2
Sarah Komaty, Ayoub Daouli, Michael Badawi, Clément Anfray, Moussa Zaarour, Samuel Valable, Svetlana Mintova
DOI: 10.1039/D0CP00111B
The effect of pulse duration on nanoparticle generation in pulsed laser ablation in liquids: insights from large-scale atomistic simulations
Maxim V. Shugaev, Chengping Wu, Leonid V. Zhigilei
DOI: 10.1039/D0CP00608D
Active stereo-control of the Cl + CH4(ν3 = 1) reaction: a three-dimensional perspective
DOI: 10.1039/D0CP01502D
您可能还喜欢
3 - (二氟甲基)-1 -氟苯(CAS号:26029-52-7)适用哪些法规指南?
3 - (二氟甲基)-1 -氟苯需遵循联合国全球化学品统一分类和标签制度(GHS),包括急性毒性、皮肤腐蚀/刺激、严重眼损伤/眼刺激等分类。同时,该化合物还需符...
3,5-二甲基苯胺(CAS号:108-69-0)通常如何合成?
3,5-二甲基苯胺通常通过乙苯的氨解反应合成。反应中使用硫酸作为催化剂,反应温度为120-130°C。乙苯在硫酸存在下与氨反应,生成3,5-二甲基苯胺和苯胺副产...
3-甲基异噻唑-5-胺(CAS号:24340-76-9)安全吗?
3-甲基异噻唑-5-胺在适当使用和储存条件下是相对安全的,但在操作时应注意防护措施。应避免吸入粉尘,避免与皮肤和眼睛直接接触。在操作过程中,应穿戴适当的防护装备...
3-(1,3-Thiazol-2-yl)-1H-indole(CAS号:135531-86-1)通常如何合成?
3-(1,3-噻唑-2-基)-1H-吲哚通常通过多步合成方法制备。首先,由噻唑-2-基溴化物和吲哚进行偶联反应,得到中间体。然后,通过还原反应将中间体转化为所需...
4-溴-2-氟苯甲基氯(CAS号:85510-82-3)的主要用途是什么?
4-溴-2-氟苯甲基氯主要用于有机合成中间体,特别是在医药、农药和染料等领域。作为一种具有特定结构的化合物,它在合成复杂有机分子时扮演重要角色。
处理Fmoc-β-(3-噻吩基)-D-Ala-OH(CAS号:220497-90-5)时应注意哪些实验室安全事项?
处理Fmoc-β-(3-噻吩基)-D-Ala-OH时,应佩戴防护手套、护目镜和实验服。操作应在通风橱内进行。如发生泄露,应立即用大量水冲洗,并通知实验室管理人员...
氮化硅(CAS号:12033-89-5)通常如何合成?
氮化硅通常通过氮化硅的直接反应合成,即在高温下将四氯化硅与氨气反应。具体步骤是将四氯化硅和氨气混合并加热至1300-1700℃,在该条件下,四氯化硅与氨气反应生...
Cetirizine EP Impurity B DiHCl(CAS号:1000690-91-4)通常如何合成?
Cetirizine EP Impurity B DiHCl通常通过一锅法合成,首先将4-氯苯基-苯甲基氯甲酸酯与1-哌嗪乙酸反应,生成相应的酸,然后与盐酸反应...
如何储存1-哌啶-4-基丁-1-酮(CAS号:3509-15-7)?
1-哌啶-4-基丁-1-酮应储存在阴凉、干燥的地方,避免阳光直射。存储容器应密封,并确保通风良好。建议储存温度不超过25℃,湿度保持在相对较低的水平。
如何处理含有VORUCICLIB(CAS号:1000023-04-0)的废料?
含有VORUCICLIB的废料应进行专业的收集和处理,包括使用适当的容器进行隔离,避免与其他化学品接触。处理方法通常包括化学中和、沉淀反应或吸附过程,随后进行焚...













![1-[3-(4-Morpholinylsulfonyl)phenyl]methanamine structure 1-[3-(4-Morpholinylsulfonyl)phenyl]methanamine structure](https://cnstatic.chemtradehub.com/structs/933/933989-32-3-51af.webp)

![tert-Butyl N-[(2-chloropyridin-4-yl)methyl]carbamate structure tert-Butyl N-[(2-chloropyridin-4-yl)methyl]carbamate structure](https://cnstatic.chemtradehub.com/structs/916/916210-27-0-9f95.webp)